长江生科(00775.HK)期望可为新合并公司Dogwood(DWTX.US)引入投资者

阿斯达克财经
Oct 08, 2024

长江生命科技(00775.HK) 宣布旗下WEX Pharmaceuticals与纳斯达克上市生物科技公司Virios Therapeutics(VIRI.US)  进行业务合并,交易完成后长江生科于VIRI持股约15.9%,并获授予可转换的优先股,当优先股转换为普通股后持股量将增至约90.7%。新合并公司将更名为Dogwood Therapeutics(DWTX.US),并维持美国上市地位。...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10